The avidity of PR3‐ANCA in patients with granulomatosis with polyangiitis during follow‐up

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical and Experimental Immunology

• Publication date

  2016-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/cei.12796PMID 27009928PMCID PMC4955002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease.

  2015cited by this paper
• Analytical issues possibly affecting the performance of commercial human cytomegalovirus IgG avidity assays

  2014cited by this paper
• Role of Cytomegalovirus (CMV) IgG Avidity Testing in Diagnosing Primary CMV Infection during Pregnancy

  2014cited by this paper
• Estimating renal survival using the ANCA-associated GN classification.

  2013cited by this paper
• Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome

  2012cited by this paper
• Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.

  2012cited by this paper
• New pathophysiological insights and treatment of ANCA-associated vasculitis.

  2011cited by this paper
• Important parameters for evaluation of antibody avidity by immunosorbent assay.

  2011cited by this paper
• Evaluation of a high avidity anti-dsDNA IgG enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus.

  2011cited by this paper
• Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis.

  2011cited by this paper
• Comparison of IgG avidity assays in the confirmation of the diagnosis of cytomegalovirus primary infection

  2010cited by this paper
• Influence of myeloperoxidase by anti-myeloperoxidase antibodies and its association with the disease activity in microscopic polyangiitis.

  2010cited by this paper
• Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis

  2009cited by this paper
• Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis.

  2009cited by this paper
• EULAR recommendations for the management of primary small and medium vessel vasculitis

  2008cited by this paper
• Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

  2008cited by this paper
• IgG subclass distribution, affinity of anti‐myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis

  2008cited by this paper
• A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis

  2008cited by this paper
• Follow‐up of avidity and titre of anti‐myeloperoxidase antibodies in sera from patients with propylthiouracil‐induced vasculitis

  2007cited by this paper
• Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies

  2006cited by this paper
• Evaluation of Commercial Rubella Immunoglobulin G Avidity Assays

  2006cited by this paper
• EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

  2006cited by this paper
• Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.

  2006cited by this paper
• Evaluation of a New Fluorescent-Enzyme Immuno-Assay for Diagnosis and Follow-up of ANCA-Associated Vasculitis

  2005cited by this paper
• Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.

  2004cited by this paper
• Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring

  2003cited by this paper
• Anca associated vasculitis: occurrence, prediction, prevention, and outcome of relapses

  2001cited by this paper
• The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis.

  1999cited by this paper
• Isotype and affinity of anti-myeloperoxidase autoantibodies in systemic vasculitis.

  1994cited by this paper
• Relevance of classic anti‐neutrophil cytoplasmic autoantibody (C‐ANCA)‐mediated inhibition of proteinase 3‐α1‐antitrypsin complexation to disease activity in Wegener's granulomatosis

  1993cited by this paper
• Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre.

  1990cited by this paper
• Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.

  1990cited by this paper
• Association between active Wegener's granulomatosis and anticytoplasmic antibodies.

  1989cited by this paper
• Antibody avidity determination by ELISA using thiocyanate elution.

  1986cited by this paper
• Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay.

  1985cited by this paper
• Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.

  1977cited by this paper
• Clinical reviews in allergy and immunology Biomarkers in connective tissue diseases

  year unknowncited by this paper

• Exploring ANCA Pathogenicity in Ulcerative Colitis: A Case Report Highlighting the Risk of Progression to ANCA-Associated Vasculitis

  2025cites this paper
• Do Relapses Follow ANCA Rises? A Systematic Review and Meta-Analysis on the Value of Serial ANCA Level Evaluation

  2022cites this paper
• Level and avidity of antineutrophil cytoplasmic antibodies specific to lactoferrin are useful biomarkers in systemic lupus erythematosus

  2021influential citation
• The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies.

  2021cites this paper
• Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies

  2021cites this paper
• Advances in therapeutic treatment options for ANCA-associated vasculitis

  2020cites this paper
• Anti-neutrophil Cytoplasmic Antibodies (ANCA) as Disease Activity Biomarkers in a “Personalized Medicine Approach” in ANCA-Associated Vasculitis

  2019cites this paper
• Antigen-Specific Detection of Autoantibodies Against Myeloperoxidase (MPO) and Proteinase 3 (PR3).

  2018cites this paper
• Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis

  2018cites this paper
• Predicting relapses in ANCA associated vasculitis

  2018cites this paper
• Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

  2017cites this paper
• Maintaining remission in patients with granulomatosis with polyangiitis or microscopic polyangiitis: the role of ANCA

  2017cites this paper
• Birmingham vasculitis activity score of more than 9.5 at diagnosis is an independent predictor of refractory disease in granulomatosis with polyangiitis

  2017cites this paper
• University of Groningen Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis Bossuyt,

  2017cites this paper
• Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

  2017cites this paper
• Clinical reviews in allergy and immunology Biomarkers in connective tissue diseases

  year unknowncites this paper